Praxis Precision Medicines to Present at Goldman Sachs Healthcare Conference

  • Praxis Precision Medicines will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 8, 2026, at 8:00 AM ET.
  • The event will be held at the Loews Miami Beach Hotel in Miami, FL.
  • A live webcast and replay will be available on Praxis’ website for 180 days.
  • Praxis focuses on CNS disorders, leveraging its Cerebrum™ and Solidus™ platforms.
  • The company has four late-stage product candidates in its portfolio.

Praxis Precision Medicines’ participation in the Goldman Sachs Healthcare Conference underscores its strategic focus on CNS disorders, a sector with significant unmet medical needs. The company’s proprietary platforms and late-stage pipeline position it within a competitive landscape of biopharmaceutical firms targeting neurological conditions. The event provides a platform to showcase its technological and therapeutic advancements to a high-profile audience of investors and industry leaders.

Pipeline Progress
How the presentation will highlight advancements in Praxis’ late-stage product candidates.
Market Positioning
Whether Praxis can differentiate itself in the competitive CNS therapeutics space.
Investor Sentiment
The impact of the conference presentation on investor confidence and stock performance.